BioElectronics Corporation Announces Substantial Increase in 4th Quarter 2020 Revenue; Major Convertible Debt Holders Agree to Forego Interest in 2021

BIEL +23.33%  Frederick, Maryland, Jan. 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC PINK:BIEL) is pleased to report that Q4 revenue for 2020 exceeded $519,000, representing an increase of 241% when compared to Q3 revenue in 2020 ($151,956). Correspondingly, Q4 2020 revenue represents an increase of 233% when compared to the cumulative revenue of … Continue Reading

BioElectronics Executes Distribution Agreement with KT Health, LLC for North American Retail Market

BioElectronics Executes Distribution Agreement with KT Health, LLC for North American Retail Market FREDERICK, MD, Dec. 15, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC PINK: BIEL), (www.bielcorp.com) is pleased to announce that it has executed an OEM agreement with KT Health, LLC to bring its innovative pain management devices to encompass retail and e-commerce … Continue Reading

BioElectronics Earns CE Mark for the ActiPatch and RecoveryRx — Drug-Free Pain Therapy Devices

Opens the Sales Market for 33+ Additional Countries FREDERICK, MD, Nov. 12, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that it has received the CE (Conformité Européenne) Mark for its ActiPatch® and RecoveryRx® Pulsed Shortwave Therapy (PSWT) medical devices. The ActiPatch is indicated for the treatment of general musculoskeletal/soft-tissue … Continue Reading

BioElectronics’ ActiPatch® Therapy To Be Marketed By DonJoy® Advantage

Drug-Free Pain Relief Technology with Premium Wraps FREDERICK, Md.,  Nov. 6, 2020 /PRNewswire/ — BioElectronics Corporation (OTC PINK: BIEL),  www.bielcorp.comis pleased to announce the execution of a commercial partnership agreement with Scott Specialties Inc (SS http://scottspecialties.com/) to bring their innovative pain management devices to the retail consumer healthcare marketplace under the DonJoy® (DJO www.djoglobal.com) Advantage product line. This commercial … Continue Reading

Richard Staelin, Ph.D. Rejoins the Board of BioElectronics Corporation

FREDERICK, MD, June 15, 2020 (GLOBE NEWSWIRE) —  via NEWMEDIAWIRE – BioElectronics Corporation (OTC: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, announced today that it has appointed Richard Staelin, Ph.D. as the Chairman of the Board following the resignation and retirement of Ms. Patricia Whelan.  “The management team at BioElectronics thanks Patricia Whelan for her … Continue Reading

BioElectronics Announces FDA Market Clearance for Over-The-Counter Treatment of Musculoskeletal Pain

FREDERICK, MD- February 3, 2020 – BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to announce that it has obtained a new 510(k) clearance from the U.S. Food and Drug Administration (FDA).  This new, over-the counter marketing clearance was granted for the drug free ActiPatch® medical device, for the … Continue Reading

BioElectronics Announces New Management Team

FREDERICK, MD- November 15, 2019 – BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that after seeking legal counsel a Board of Directors, President and Chief Executive Officer have been appointed/re-affirmed. These changes follow the unexpected passing of the Company’s founder, President and CEO Mr. Andrew Whelan, in October 2019. Pursuant to Section … Continue Reading

BioElectronics Founder and CEO Andrew J. Whelan Has Died Suddenly

FREDERICK, MD, Oct. 07, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BioElectronics Corp. (OTCPK: BIEL) is sad to announce that its founder and CEO, Andrew J. Whelan, died suddenly last night at his home in Frederick, Maryland. The BioElectronics management team will continue to manage day-to-day operations until a permanent replacement can be confirmed. Mr. … Continue Reading

BioElectronics Announces Publication of a Study of the ActiPatch® Medical Device as an Effective Long Term Treatment for Chronic Pain

FREDERICK, MD- Oct 02, 2019 – BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com , the maker of non-invasive electroceutical devices, is pleased to announce the publication of a study in the journal Pain Research and Management, titled “A Prospective Six-Month Study of Chronic Pain Sufferers: A Novel OTC Neuromodulation Therapy”. The study demonstrated that users who … Continue Reading

BioElectronics Files FDA 510(k) Application for Musculoskeletal Pain Complaints; Clinical Data Demonstrates Superior Drug Free Pain Relief to Prescription Strength NSAID Drug

FREDERICK, MD, Aug. 20, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has filed a 510(k), Premarket Notification application with the U.S. Food and Drug Administration (FDA). The application is to seek expanded market clearance for the drug free, over-the-counter ActiPatch® Musculoskeletal Pain Therapy medical … Continue Reading